Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2020-01-15 2019-05-21
Drug Identification Number 02231675 02231675
Brand name COMBIVENT UDV COMBIVENT UDV
Common or Proper name Combivent UDV (0.5 mg/2.5mg) Combivent UDV (0.5 mg/2.5mg)
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients IPRATROPIUM BROMIDE SALBUTAMOL IPRATROPIUM BROMIDE SALBUTAMOL
Strength(s) 0.2MG 1.0MG 0.2MG 1.0MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION
Packaging size 20s 20s
ATC code R03AL R03AL
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-09-30 2019-09-30
Actual discontinuation date 2020-01-08
Remaining supply date 2019-11-30 2019-09-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments